Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (groß) | News | Bilanz/GuV | Dividende/HV | Zertifikate | Depot |
Times + Sales | Chart-Analyse | Analysen | Schätzungen | Termine | Optionsscheine | Watchlist |
Börsenplätze | Chartvergleich | Kursziele | Vergleich | Profil | Knock-Outs | Kaufen |
Orderbuch | Realtime Stuttgart | myNews | Insidertrades | Fonds | im Forum | |
Historisch | Realtime Push | Anleihen |
Freefloat | 105,67 % |
Größte Anteilseigner | in % |
---|---|
Point72 Asset Management LP (Old) | 3,74 |
Fidelity Management & Research Co. LLC | 2,87 |
Altium Capital Management LP | 1,33 |
Alexey L. Margolin, PhD | 1,01 |
Banco Bilbao Vizcaya Argentaria SA | 0,93 |
Vifag 2002, SICAV | 0,87 |
FCP Medical - BioHealth | 0,84 |
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | - | - | 83 | 41 | 22 |
Umsatz pro Mitarbeiter in Mio. USD | - | - | 0,00 | 0,00 | 0,00 |
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 96 | 64 | 33 | 37 | 33 |
Summe Anlagevermögen | 92 | 59 | 28 | 33 | 29 |
Summe Aktiva | 96 | 65 | 34 | 39 | 35 |
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 9 | 10 | 10 | 11 | 10 |
Summe Fremdkapital | 13 | 16 | 17 | 16 | 16 |
Summe Eigenkapital | 83 | 49 | 17 | 23 | 19 |
Summe Passiva | 96 | 65 | 34 | 39 | 35 |
One Newton Executive Park, 02462 Newton | |
Tel: | 1.617.467.4577 |
Fax: | 1.617.916.1871 |
Internet | http://www.allenapharma.com |
Alexey L. Margolin Chairman |
Allene M. Diaz Independent Director |
Ann Calby Miller Independent Director |
David J. Clark Chief Medical Officer |
Geoffrey A. Swire COO & Senior Vice President-Corporate Development |
Geoffrey A. Swire Vice President-Business Development & Strategy |
Gino Santini Lead Independent Director |
Hugh Wight Senior Vice President-Technical Operations |
Louis Brenner President, Chief Executive Officer & Director |
Mark J. Fitzpatrick Independent Director |
Michael Patrick Miller Director |
Richard D. Katz Chief Financial Officer |
ETF-Sparplan